With a growing number of Zofran birth defect lawsuits continuing to be filed by families throughout the U.S., each raising similar allegations that GlaxoSmithKline failed to adequately warn about the risks associated with using the medication during pregnancy, the litigation has been consolidated in the federal… Read More
Due to inadequate and misleading pregnancy warnings provided by GlaxoSmithKline, there is a false impression among consumers and the medical community that Zofran is safe for pregnant women. However, thousands of children through the U.S. may have developed heart defects, oral cleft defects and other congenital… Read More
A motion has been filed in the federal court system to centralize all Zofran birth defect lawsuits before one judge as part of an MDL, or Multidistrict Litigation. While such coordinated pretrial proceedings are often confused with a Zofran class action, there are important differences and… Read More
Although Zofran is widely prescribed during pregnancy for morning sickness or hyperemesis gravidarum (HG), there is growing evidence that the medication may increase the risk of birth defects and congenital malformations for children. While further studies on the safety of Zofran in pregnancy are needed, there… Read More
The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Zofran lawsuits for children born with birth defects or malformations that may have been caused by exposure to the morning sickness drug during the first trimester of pregnancy. Although Zofran has been widely prescribed… Read More
